ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.122G>A (p.Arg41Lys)

gnomAD frequency: 0.00001  dbSNP: rs34831026
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000756230 SCV000883976 likely benign not provided 2023-11-22 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000756230 SCV000889360 likely benign not provided 2022-12-22 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002265556 SCV002548061 likely benign not specified 2024-05-07 criteria provided, single submitter clinical testing Variant summary: HBB c.122G>A (p.Arg41Lys) results in a conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251398 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.122G>A has been reported in the literature as Hb-Athens-Georgia/Hb-Waco and has been associated with normal hematological parameters, a normal heme-heme interaction, normal Bohr effect, normal/reduced heme-heme interaction and increased oxygen affinity (example, Brown_1976, Moo-Penn_1977, Mrad_1989). It has recently been reported in a family with HbH disease resulting from alpha thalassemia deletions where the impact of this beta globin variant was not significant and a family member had normal hematological parameters with the authors concluding that this variant is non-pathological (example, Panyasai_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Hemoglobinopathy. The following publications have been ascertained in the context of this evaluation (PMID: 14597, 8114, 2757008, 33287582). ClinVar contains an entry for this variant (Variation ID: 15099). Based on the evidence outlined above, the variant was classified as likely benign.
Revvity Omics, Revvity RCV000756230 SCV004235263 uncertain significance not provided 2023-02-09 criteria provided, single submitter clinical testing
OMIM RCV000016252 SCV000036520 other HEMOGLOBIN ATHENS-GEORGIA 2017-12-12 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.